N/A Completed N=26 Randomized Single-blind Treatment

Study of the Effect of Individualizing Daytrana Wear-times on Sleep in Children With ADHD

Attention Deficit Hyperactivity Disorder · Insomnia

Source: ClinicalTrials.gov NCT00989950 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jun 2012

Primary outcomePrimary: Sleep Latency — 34; 34; 32; 34 minutes — p=0.588

Summary

Methylphenidate may improve sleep in children with ADHD. By leaving Daytrana (methylphenidate) patch for a longer time then 9 hours, many children report short sleep latencies and better quality of sleep.

Outcome Measures

Outcome	Result	p-value
PRIMARY Sleep Latency	34; 34; 32; 34	0.588

Eligibility Criteria

Inclusion Criteria

ADHD without significant comorbidity

Exclusion Criteria

Cardiac disorder
Hypertension
Thyroid disease
Glaucoma
History of sudden death, motor tics and/or Tourette's syndrome
Hypersensitivity to methylphenidate

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00989950). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.